Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Director departure
Appointed director
Notes underwriting agrmnt
|
|
SANUWAVE Health, Inc. (SNWV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
8-K
| Quarterly results |
| 05/12/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results|
Docs:
|
"Press Release",
"Eden Prairie, MN, August 15, 2022 - SANUWAVE Health, Inc. a leading provider of next-generation wound care products, reported financial results for their second quarter, ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call on Tuesday August 16, 2022, at 12:30 to provide a business update . Quarter Highlights: - Over 50 systems placed to treat wounds o 100% increase from the 25 systems placed Q2 2021 - Over 40,000 wound treatments administered o Up from 31,000 treatments administered Q2 2021 - Successfully completed MDSAP audit - Transitioned company from Suwanee GA to Eden Prairie MN - Became current on SEC filings - Launched Cosmetic and Orthopedics verticals with initial sales in each “Our key ENERGY FIRST products, dermaPACE® and Ul..." |
|
| 05/27/2020 |
8-K
| Quarterly results |
| 05/18/2020 |
8-K
| Quarterly results|
Docs:
|
"SANUWAVE HEALTH REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS SUWANEE, GA, May 18, 2020 - SANUWAVE Health, Inc. reported financial results for the quarter ended March 31, 2020 with the SEC on Friday, May 15, 2020. The Company will also host a conference call today, May 18, 2020, at 10:00 a.m. Eastern Time. Highlights from the quarter: ● Launched dermaPACE® System solutions to treat patients in a home setting. Initial 10 sites successfully targeted for implementation. ● Placements have begun in “Open States” in earnest as of last week. Backlog for placements continues to grow for when open activity resumes, everywhere. ● Entered into an agreement to place dermaPACE® Systems with Mobile Health Systems , a business recently launched by former SANUWA..." |
|
| 11/18/2019 |
8-K
| Quarterly results |
| 08/19/2019 |
8-K
| Quarterly results|
Docs:
|
"SANUWAVE HEALTH REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS SUWANEE, GA, August 15, 2019 - SANUWAVE Health, Inc. reported financial results for the three months ended June 30, 2019 with the SEC on Wednesday, August 14, 2019. The Company will also host a conference call today, August 15, 2019, 2019 at 9:00 a.m. Eastern Time. Highlights from the second quarter and last few weeks: ● Placed 36 dermaPACE® Systems in the United States, exceeding expectation of 35 devices by end of second quarter. On track to reach 65 by end of third quarter and 110 by year end. ● NGS change in reimbursement status leads to adding 10 new states to the strategic growth plan. Accelerating placement plan by one full year. ● Presented abstracts, symposium, and posters at 5 conferences in s...",
"CONFERENCE CALL TRANSCRIPTION" |
|
| 04/03/2019 |
8-K
| Quarterly results|
Docs:
|
"SANUWAVE HEALTH REPORTS RECORD 2018 FINANCIAL RESULTS FULL YEAR REVENUE INCREASED OVER 150% SUWANEE, GA, March 29, 2019 – SANUWAVE Health, Inc. will report financial results for the year ended December 31, 2018 with the SEC on Monday, April 1, 2019. The Company will also host a conference call today, March 29, 2019 at 10:00 a.m. Eastern Time. Highlights from 2018: ● Hired Shri Parikh as President, Healthcare in May 2018. ● Received insurance reimbursement tracking codes for Diabetic Foot Ulcer procedure using ESWT. ● Signed Premier Shockwave Wound Care, Inc. as the exclusive distributor of dermaPACE® for the Veteran’s Administration , Indian Health Services and Tribally-operated healthcare services. ● First shipments of the dermaPACE system in the U.S. Mark...",
"FINANCIAL STATEMENTS" |
|
| 05/18/2018 |
8-K
| Quarterly results|
Docs:
|
"SANUWAVE HEALTH REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE SUWANEE, GA, May 16, 2018 – SANUWAVE Health, Inc. reported financial results for the three months ended March 31, 2018 with the SEC on Tuesday, May 15, 2018 and will provide a business update on a conference call today, May 16, 2018 at 9:00 a.m. Eastern Time. Highlights: ● Revenue for the first quarter of 2018 was $344,272 up 130% from the first quarter of 2017. ● Shipped first US dermaPACE® devices in February 2018. ● Entered into an exclusive agreement for purchase and sale of dermaPACE® Systems to certain governmental healthcare facilities with Premier Shockwave Wound Care, Inc. and Premier Shockwave, Inc. The contract includes a minimum purchase of 100 units over 3 year...",
"to this Form 8-K" |
|
| 04/02/2018 |
8-K
| Quarterly results|
Docs:
|
"SANUWAVE HEALTH REPORTS 2017 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE SUWANEE, GA, March 29, 2018 – SANUWAVE Health, Inc. reported financial results for the year ended December 31, 2017 with the SEC on Thursday, March 29, 2018 and provided a business update. The Company will also host a conference call today, March 29, 2018 at 9:00 a.m. Eastern Time. Highlights of 2017: ● Received de novo clearance from the FDA December 28, 2017 for use of the dermaPACE® System in treating Diabetic Foot Ulcers . ● Signed Brazilian JV with MundiMed worth north of $25 million in net present value during fourth quarter of 2017. ● International footprint expanded from 5 active countries to 10 during 2017. ● Hired André Mouton as Vice President of International Sale...",
"CONFERENCE CALL" |
|
| 11/22/2017 |
8-K
| Quarterly results |
| 08/17/2017 |
8-K
| Quarterly results |
| 05/18/2017 |
8-K
| Quarterly results |
| 04/06/2017 |
8-K
| Form 8-K - Current report |
| 11/14/2016 |
8-K
| Quarterly results |
| 08/17/2016 |
8-K
| Quarterly results |
| 05/17/2016 |
8-K
| Quarterly results |
| 04/01/2016 |
8-K
| Quarterly results |
| 11/16/2012 |
8-K
| Quarterly results|
Docs:
|
"SANUWAVE Health, Inc. Barry Jenkins, 678-578-0103 Chief Operating Officer [email protected] SANUWAVE HEALTH, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, 2012 December 31, 2011 ASSETS CURRENT ASSETS Cash and cash equivalents $ 361,263 $ 3,909,383 Accounts receivable - trade, net 78,287 81,565 Inventory 294,898 396,284 Prepaid expenses 203,132 162,975 Due from Pulse Veterinary Technologies, LLC - 27,837 TOTAL CURRENT ASSETS 937,580 4,578,044 PROPERTY AND EQUIPMENT, at cost, less accumulated depreciation 37,904 51,206 OTHER ASSETS 3,191 3,192 INTANGIBLE ASSETS, at cost, less accumulated amortization 1,303,715 1,533,782 TOTAL ASSETS $ 2,282,390 $ 6,166,224 LIABILITIES CURRENT LIABILITIES Accounts payable $ 402,358 $ 756,657 Accrued employee compensat..." |
|
| 08/13/2012 |
8-K
| Quarterly results |
| 05/16/2012 |
8-K
| Quarterly results|
Docs:
|
"SANUWAVE Health, Inc. Barry Jenkins, 678-578-0103 Chief Financial Officer or Bernie Laurel, 678-578-0103 VP of Sales and Marketing [email protected] SANUWAVE HEALTH, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS March 31, December 31, 2012 2011 ASSETS CURRENT ASSETS Cash and cash equivalents $ 2,421,809 $ 3,909,383 Accounts receivable - trade, net 126,131 81,565 Inventory 358,341 396,284 Prepaid expenses 171,705 162,975 Due from Pulse Veterinary Technologies, LLC - 27,837 TOTAL CURRENT ASSETS 3,077,986 4,578,044 PROPERTY AND EQUIPMENT, at cost, less accumulated depreciation 46,941 51,206 OTHER ASSETS 3,321 3,192 INTANGIBLE ASSETS, at cost, less accumulated amortization 1,457,093 1,533,782 TOTAL ASSETS $ 4,585,341 $ 6,166,224 LIABILITIES CURRENT LIABILITIES Accou..." |
|
| 11/15/2011 |
8-K
| Form 8-K - Current report |
| 08/10/2011 |
8-K
| Form 8-K - Current report |
| 11/12/2010 |
8-K
| Form 8-K - Current report |
| 08/16/2010 |
8-K
| Quarterly results, Entered into an underwriting agreement for the issuance and sale of notes |
|
|